Aligned Genetics Statistics

Total Valuation

Aligned Genetics has a market cap or net worth of KRW 47.31 billion. The enterprise value is 35.36 billion.

Market Cap	47.31B
Enterprise Value	35.36B

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Aligned Genetics has 14.38 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	14.38M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.84%
Owned by Institutions (%)	n/a
Float	6.75M

Valuation Ratios

The trailing PE ratio is 19.09.

PE Ratio	19.09
Forward PE	n/a
PS Ratio	3.15
PB Ratio	1.43
P/TBV Ratio	1.44
P/FCF Ratio	19.20
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.69, with an EV/FCF ratio of 14.35.

EV / Earnings	14.27
EV / Sales	2.36
EV / EBITDA	10.69
EV / EBIT	13.02
EV / FCF	14.35

Financial Position

The company has a current ratio of 17.95, with a Debt / Equity ratio of 0.09.

Current Ratio	17.95
Quick Ratio	13.90
Debt / Equity	0.09
Debt / EBITDA	0.94
Debt / FCF	1.22
Interest Coverage	13.59

Financial Efficiency

Return on equity (ROE) is 7.71% and return on invested capital (ROIC) is 4.57%.

Return on Equity (ROE)	7.71%
Return on Assets (ROA)	4.03%
Return on Capital (ROIC)	4.57%
Revenue Per Employee	227.26M
Profits Per Employee	37.55M
Employee Count	66
Asset Turnover	0.37
Inventory Turnover	0.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.69% in the last 52 weeks. The beta is 0.30, so Aligned Genetics's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-20.69%
50-Day Moving Average	3,075.40
200-Day Moving Average	3,535.63
Relative Strength Index (RSI)	61.14
Average Volume (20 Days)	85,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aligned Genetics had revenue of KRW 15.00 billion and earned 2.48 billion in profits. Earnings per share was 172.36.

Revenue	15.00B
Gross Profit	10.82B
Operating Income	2.61B
Pretax Income	3.10B
Net Income	2.48B
EBITDA	3.20B
EBIT	2.61B
Earnings Per Share (EPS)	172.36

Full Income Statement

Balance Sheet

The company has 14.96 billion in cash and 3.01 billion in debt, giving a net cash position of 11.94 billion or 830.72 per share.

Cash & Cash Equivalents	14.96B
Total Debt	3.01B
Net Cash	11.94B
Net Cash Per Share	830.72
Equity (Book Value)	32.99B
Book Value Per Share	2,294.44
Working Capital	20.62B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.65 billion and capital expenditures -189.31 million, giving a free cash flow of 2.46 billion.

Operating Cash Flow	2.65B
Capital Expenditures	-189.31M
Free Cash Flow	2.46B
FCF Per Share	171.35

Full Cash Flow Statement

Margins

Gross margin is 72.14%, with operating and profit margins of 17.41% and 16.52%.

Gross Margin	72.14%
Operating Margin	17.41%
Pretax Margin	20.65%
Profit Margin	16.52%
EBITDA Margin	21.35%
EBIT Margin	17.41%
FCF Margin	16.43%

Dividends & Yields

Aligned Genetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.24%
FCF Yield	5.21%

Stock Splits

The last stock split was on November 7, 2023. It was a forward split with a ratio of 2.

Last Split Date	Nov 7, 2023
Split Type	Forward
Split Ratio	2

Scores

Aligned Genetics has an Altman Z-Score of 5.45.

Altman Z-Score	5.45
Piotroski F-Score	n/a